Clinical Trial: A Repeat Dose Study of the Dexmedetomidine Transdermal System in Healthy Subjects

U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07818330) titled 'A Repeat Dose Study of the Dexmedetomidine Transdermal System in Healthy Subjects' on Sept. 07.

Brief Summary: This Phase 1, 16-day Repeat dose study will evaluate the safety of a Dexmedetomidine Transdermal System (DMTS) skin system in healthy adults Subjects. Participants will receive the patch for four consecutive 4-day treatment periods. Researchers will monitor safety, drug levels in the blood, sedation effects, skin irritation, and how well the patch stays attached to the skin.

Study Start Date: Oct. 30

Study Type: INTERVENTIONAL

Condition: Healthy Subjects

Intervention: DRUG: Dexmedetomidine Transdermal System (DMTS) ...